| 2025-11-06 |
详情>>
股本变动：
变动后总股本10951.02万股
|
| 2025-11-06 |
详情>>
业绩披露：
2025年三季报(累计)每股收益0.34美元,归母净利润3736.40万美元,同比去年增长30.67%
|
| 2025-11-03 |
财报披露：
美东时间 2025-11-03 盘后发布财报
|
| 2025-11-01 |
详情>>
内部人交易：
Kokes Mark股份减少6259.00股
|
| 2025-08-07 |
详情>>
业绩披露：
2025年中报每股收益0.26美元,归母净利润2853.60万美元,同比去年增长207.47%
|
| 2025-05-06 |
详情>>
业绩披露：
2025年一季报每股收益0.11美元,归母净利润1181.40万美元,同比去年增长1214.13%
|
| 2025-03-26 |
股东大会：
将于2025-05-08召开股东大会
会议内容 ▼▲
- 1.To elect seven members of the Board of Directors to hold office until the next annual meeting or until their successors are duly elected and qualified
2. To hold an advisory vote to approve the compensation of our named executive officers as described in this proxy statement;
3.To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2025
4.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2025-02-19 |
详情>>
业绩披露：
2022年年报每股收益-2.83美元,归母净利润-2.96亿美元,同比去年增长-433.53%
|
| 2025-02-19 |
详情>>
业绩披露：
2024年年报每股收益0.59美元,归母净利润6462.30万美元,同比去年增长-4.08%
|
| 2024-11-12 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.26美元,归母净利润2859.50万美元,同比去年增长-47.7%
|
| 2024-08-07 |
详情>>
业绩披露：
2023年中报每股收益0.29美元,归母净利润3044.00万美元,同比去年增长57.57%
|
| 2024-08-07 |
详情>>
业绩披露：
2024年中报每股收益0.09美元,归母净利润928.10万美元,同比去年增长-69.51%
|
| 2024-05-08 |
详情>>
业绩披露：
2024年一季报每股收益0.01美元,归母净利润89.90万美元,同比去年增长-96.9%
|
| 2024-03-27 |
股东大会：
将于2024-05-09召开股东大会
会议内容 ▼▲
- 1.To elect seven (7) members of the Board of Directors to hold office until the next annual meeting or until their successors are duly elected and qualified
2.To hold an advisory vote to approve the compensation of our named executive officers as described in this proxy statement;
3.To approve an Amended and Restated 2020 Equity Incentive Plan;
4.To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2024
5.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2024-02-23 |
详情>>
业绩披露：
2023年年报每股收益0.63美元,归母净利润6737.20万美元,同比去年增长122.77%
|
| 2023-11-06 |
详情>>
业绩披露：
2023年三季报(累计)每股收益0.51美元,归母净利润5467.20万美元,同比去年增长114.79%
|
| 2023-04-12 |
股东大会：
将于2023-05-25召开股东大会
会议内容 ▼▲
- 1.To elect five (5) members of the Board of Directors to hold office until the next annual meeting or until their successors are duly elected and qualified;
2.To hold an advisory vote to approve the compensation of our named executive officers as described in the proxy statement;
3.To conduct a non-binding advisory vote on the frequency of future non-binding advisory votes on executive compensation;
4.To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2023;
5.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2022-03-16 |
股东大会：
将于2022-04-29召开股东大会
会议内容 ▼▲
- 1.To elect eight (8) members of the Board of Directors to hold office until the next annual meeting or until their successors are duly elected and qualified;
2.To approve an amendment to the Company’s 2020 Equity Incentive Plan to increase the number of shares reserved for issuance by an additional 8,800,000 shares of common stock;
3.To approve an amendment to the Company’s 2020 Employee Stock Purchase Plan to increase the number of shares reserved for issuance by an additional 6,000,000 shares of common stock;
4.To hold an advisory vote to approve the compensation of our named executive officers as described in the proxy statement;
5.To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2022;
6.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2021-03-31 |
股东大会：
将于2021-05-14召开股东大会
会议内容 ▼▲
- 1.To elect seven (7) members of the Board of Directors to hold office until the next annual meeting or until their successors are duly elected and qualified;
2.To hold an advisory vote to approve the compensation of our named executive officers as described in the proxy statement;
3.To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its year ending December 31, 2021;
4.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2020-04-20 |
股东大会：
将于2020-05-29召开股东大会
会议内容 ▼▲
- 1.To consider and vote on a proposal (the “Xperi merger proposal”) to adopt the Agreement and Plan of Merger and Reorganization, dated as of December 18, 2019, as amended on January 31, 2020 (as it may be further amended from time to time, the “merger agreement”), by and among Xperi Corporation, a Delaware corporation (“Xperi”), TiVo Corporation, a Delaware corporation (“TiVo”), XRAY-TWOLF HoldCo Corporation, a Delaware corporation (“HoldCo”), XRAY Merger Sub Corporation, a Delaware corporation (“Xperi Merger Sub”) and TWOLF Merger Sub Corporation, a Delaware corporation (“TiVo Merger Sub”), a copy of which is attached as Annex A to the joint proxy statement/prospectus accompanying this notice;
2.To consider and vote on a proposal to adjourn the Xperi special meeting (as defined below), if necessary or appropriate, to solicit additional proxies if there are not sufficient votes to approve the Xperi merger proposal (the “Xperi adjournment proposal”);
3.To consider and vote on a non-binding, advisory proposal to approve the compensation that may become payable to Xperi’s named executive officers in connection with the consummation of the mergers (the “Xperi compensation proposal”).
|
| 2019-12-19 |
复牌提示：
2019-12-19 06:58:06 停牌，复牌日期 2019-12-19 07:30:00
|
| 2019-03-20 |
股东大会：
将于2019-05-03召开股东大会
会议内容 ▼▲
- 1.To elect seven (7) members of the Board of Directors to hold office until the next annual meeting or until their successors are duly elected and qualified;
2.To approve the Company’s Second Amended and Restated International Employee Stock Purchase Plan;
3.To hold an advisory vote to approve executive compensation;
4.To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accountants of the Company for its year ending December 31, 2019;
5.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2018-03-14 |
股东大会：
将于2018-04-27召开股东大会
会议内容 ▼▲
- 1.To elect seven (7) members of the Board of Directors to hold office until the next annual meeting or until their successors are duly elected and qualified;
2.To approve the Company’s Seventh Amended and Restated 2003 Equity Incentive Plan;
3.To approve the Company’s Amended and Restated 2003 Employee Stock Purchase Plan;
4.To hold an advisory vote to approve executive compensation;
5.To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accountants of the Company for its year ending December 31, 2018;
6.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2017-03-15 |
股东大会：
将于2017-04-27召开股东大会
会议内容 ▼▲
- 1. To elect seven (7) members of the Board of Directors to hold office until the next annual meeting or until their successors are duly elected and qualified;
2. To approve the Xperi Corporation 2017 Performance Bonus Plan for Executive Officers and Key Employees;
3. To approve the Xperi Corporation Amended and Restated International Employee Stock Purchase Plan;
4. To hold an advisory vote on executive compensation;
5. To hold an advisory vote on the frequency of the advisory vote on executive compensation;
6. To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accountants of the Company for its year ending December 31, 2017;
7. To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|